Table 1 The clinical features of patient groups
From: Testicular expression of TDRD1, TDRD5, TDRD9 and TDRD12 in azoospermia
Patient groups | Number of patients | Genetic analysis | Age of patients (years) | LH (mIU/ml) | FSH (mIU/ml) | Testosterone (ng/ml) |
|---|---|---|---|---|---|---|
OA | 29 | 46XY/ normal AZF | 34.3 ± 2.3 | 8.34 ± 1.12 | 9.21 ± 1.27 | 4.41 ± 0.34 |
HP | 28 | 46XY/ normal AZF | 31.5 ± 2.4 | 7.92 ± 1.18 | 9.32 ± 1.13 | 4.35 ± 0.22 |
MA | 30 | 46XY/ normal AZF | 33. 4 ± 2.1 | 7.93 ± 1.35 | 9.42 ± 1.61 | 4.43 ± 0.33 |
SCOS | 32 | 46XY/ normal AZF | 30.4 ± 2.1 | 8.62 ± 1.61 | 9.73 ± 1.42 | 4.45 ± 0.34 |
P-value | – | – | NS | NS | NS | NS |